Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gabriël, Jacobs"'
Autor:
Ahnjili Zhuparris, Ghobad Maleki, Liesbeth van Londen, Ingrid Koopmans, Vincent Aalten, Iris E. Yocarini, Vasileios Exadaktylos, Albert van Hemert, Adam Cohen, Pim Gal, Robert-Jan Doll, Geert Jan Groeneveld, Gabriël Jacobs, Wessel Kraaij
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Drug development for mood disorders can greatly benefit from the development of robust, reliable, and objective biomarkers. The incorporation of smartphones and wearable devices in clinical trials provide a unique opportunity to monitor beha
Externí odkaz:
https://doaj.org/article/7fc77d26e65c4a94b6761c3ca90e1519
Autor:
Francis Dijkstra, Patricio O’Donnell, Erica Klaassen, Derek Buhl, Mahnaz Asgharnejad, Laura Rosen, Rob Zuiker, Joop van Gerven, Gabriël Jacobs
Publikováno v:
Translational Psychiatry, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract TAK-653 is a novel AMPA receptor positive allosteric modulator in clinical development for the treatment of major depressive disorder (MDD). This study aimed to measure the functional pharmacodynamic central nervous system (CNS) effects of T
Externí odkaz:
https://doaj.org/article/62a8cd476bd44bbca0c331fce96852f3
Autor:
Daniël, Kleinloog, Marieke, Liem-Moolenaar, Gabriël, Jacobs, Erica, Klaassen, Marieke, de Kam, Ron, Hijman, Joop, van Gerven
Publikováno v:
Journal of psychopharmacology (Oxford, England). 26(10)
Δ⁹-Tetrahydrocannabinol (THC) produces transient psychomimetic effects in healthy volunteers, constituting a pharmacological model for psychosis. The dopaminergic antagonist haloperidol has previously been shown to reduce these effects. This place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d28b9ddd215c6c1a20332141cd95235
https://pubmed.ncbi.nlm.nih.gov/22596206
https://pubmed.ncbi.nlm.nih.gov/22596206